Characteristics and outcomes of patients with pediatric-onset non-mastocytosis mast cell activation disorders: A CEREMAST study.
Weiss M, Rossignol J, Campeotto F, Foy E, Elbany C, Jaume L, Geroux L, Debeaupuis O, Neuraz A, Bekel L, Lezmi G, Bellon N, Méni C, Livideanu C, Madrange M, Condé D, Agopian J, Michot C, Villard-Truc F, Lachaux A, Greco C, Hadj-Rabia S, Dubreuil P, Hermine O, Bodemer C, Polivka L.
Weiss M, et al.
Pediatr Allergy Immunol. 2026 May;37(5):e70373. doi: 10.1111/pai.70373.
Pediatr Allergy Immunol. 2026.
PMID: 42149735
Free PMC article.
MCAD not fulfilling mastocytosis or all MCAS criteria are referred to as MCAD not otherwise specified (MCAD-NOS). The aim was to describe the clinical, laboratory characteristics and outcomes of the first pediatric-onset non-mastocytosis MCAD cohort. ...Before 3 years of a …
MCAD not fulfilling mastocytosis or all MCAS criteria are referred to as MCAD not otherwise specified (MCAD-NOS). The aim was to desc …